Last edition
News about "Advanced Diagnostic Laboratory Testing (ADLT)"
Tempus Wins FDA Approval for xT CDx, Expanding Solid Tumor Testing Portfolio
Tempus has received US FDA approval for its tumor-only xT CDx, becoming the first laboratory with companion diagnostic approval for both tumor-only and tumor-normal genomic profiling.
Advanced Diagnostic Laboratory Testing (ADLT) | 30/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members